NCT03444155

Brief Summary

In a cross-over study the investigators evaluate the effects of natural (Panmol-B-Complex) (Pan \[Greek\] = all; moles \[Latin\] = molecules/particles - brand name) versus synthetic vitamin B complexes to identify the bioavailability of distinct vitamins as well as long-term effects. The primary hypothesis for this study: "Natural Vitamin B-complexes are as effective as synthetic Vitamin B-complexes or better." For this reason 30 subjects (18 to 65y; BMI \>19 to \<29) were recruited for this study. The study population was divided into 2 groups of each 15 subjects in a cross-over trial. Vitamin supplementation consisted of Thiamine (2.93 mg), Riboflavin (3.98 mg), Niacin (29.85 mg), Pantothenic acid (10.95 mg), Pyridoxine (3.38 mg), Biotin (0.108 mg), Folic acid (0.69 mg) and Cobalamin (8.85 µg) per day in both groups. Blood samples are taken at baseline - 1.5h after vitamin supplementation - 4h - 7h - 6 weeks - wash out phase I (2 weeks); start cross-over: baseline - 1.5h after vitamin supplementation - 4h - 7h - 6 weeks - washout phase II (6 weeks). In case of main target criteria Thiamin, Riboflavin, Pyridoxine, Folic acid and Cobalamin were measured in serum as well as total peroxides (µmol/L), peroxidase-activity (U/L), total antioxidant status (mmol/L) and polyphenols (mmol/L).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 8, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 3, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 17, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 8, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 23, 2018

Completed
3.2 years until next milestone

Results Posted

Study results publicly available

April 26, 2021

Completed
Last Updated

April 26, 2021

Status Verified

April 1, 2021

Enrollment Period

5 months

First QC Date

January 8, 2018

Results QC Date

February 14, 2020

Last Update Submit

April 23, 2021

Conditions

Outcome Measures

Primary Outcomes (5)

  • Serum Thiamine

    Serum Thiamine in microgram per liter Minimum: 36 Maximum: 98

    20 weeks

  • Serum Riboflavin

    Serum Riboflavin in microgram per liter Minimum: 190 Maximum: 341

    20 weeks

  • Serum Pyridoxine

    Serum Pyridoxine in microgram per liter Minimum: 3.8 Maximum: 161.8

    20 weeks

  • Serum Folic Acid

    Serum Folic acid in nanogram per liter Minimum: 2.20 Maximum: 58.10

    20 weeks

  • Serum Cobalamin

    Serum Cobalamin in picogram per liter Minimum: 159 Maximum: 1230

    20 weeks

Secondary Outcomes (5)

  • Serum Total Peroxides

    20 weeks

  • Serum Total Antioxidant Capacity

    20 weeks

  • Serum Endogenous Peroxidase-activity

    20 weeks

  • Serum Polyphenols

    20 weeks

  • Total Homocysteine

    20 weeks

Study Arms (2)

Natural Panmol-B-Complex first, then synthetic Vitamin B-complex

ACTIVE COMPARATOR

Participants first received a Natural Vitamin B-complex, i.e., Panmol-B-Complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks. After a wash-out period of 2 weeks, they then received a synthetic Vitamin B-complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks.The study finished after the second wash-out period for another 6 weeks.

Dietary Supplement: Natural Panmol-B-Complex

Synthetic Vitamin B-complex first, then Natural Panmol-B-Complex

ACTIVE COMPARATOR

Participants first received a Synthetic Vitamin B-complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks. After a wash-out period of 2 weeks, they then received a natural Vitamin B-complex, i.e., Panmol-B-complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks.The study finished after the second wash-out period for another 6 weeks.

Dietary Supplement: Synthetic Vitamin B-Complex

Interventions

Natural Panmol-B-ComplexDIETARY_SUPPLEMENT

Natural Panmol-B-Complex: B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) - Synthetic Vitamin B-Complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg)

Natural Panmol-B-Complex first, then synthetic Vitamin B-complex
Synthetic Vitamin B-ComplexDIETARY_SUPPLEMENT

Synthetic Vitamin B-Complex: B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85µg) - Natural Panmol-B-Complex: B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg)

Synthetic Vitamin B-complex first, then Natural Panmol-B-Complex

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female
  • Healthy

You may not qualify if:

  • Cholesterol \>240mg/dl
  • Pregnancy and lactation period
  • Clinical diagnosis of chronic infections
  • Ingestion of trace elements, vitamin- and fatty acid supplements in the past 3 months
  • Clinical diagnosis of cardiovascular disease
  • Clinical diagnosis of cancer
  • Clinical diagnosis of psychotic diseases
  • Insulin dependent diabetes
  • Clinical diagnosis of autoimmune diseases
  • Maldigestion/Malabsorption
  • Veganes cuisine
  • \> 1 Beer/day

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wonisch Willibald

Graz, Styria, 8036, Austria

Location

Related Publications (2)

  • Lindschinger M, Tatzber F, Schimetta W, Schmid I, Lindschinger B, Cvirn G, Stanger O, Lamont E, Wonisch W. A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels. Oxid Med Cell Longev. 2019 Dec 12;2019:6082613. doi: 10.1155/2019/6082613. eCollection 2019.

  • Lindschinger M, Tatzber F, Schimetta W, Schmid I, Lindschinger B, Cvirn G, Fuchs N, Markolin G, Lamont E, Wonisch W. [Bioavailability of natural versus synthetic B vitamins and their effects on metabolic processes]. MMW Fortschr Med. 2020 Mar;162(Suppl 4):17-27. doi: 10.1007/s15006-020-0230-4. Epub 2020 Mar 19. German.

MeSH Terms

Conditions

Vitamin B 6 DeficiencyVitamin B 12 DeficiencyMetabolic Diseases

Condition Hierarchy (Ancestors)

Vitamin B DeficiencyAvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Results Point of Contact

Title
Dr. Willibald Wonisch
Organization
Otto Loewi Research Center, Chair of Physiological Medicine, Medical University of Graz, Austria

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Masking was organized and supervised by the randomization person in charge. Group assignment was 1:1 (control vs. verum group) with identical packages for both Vitamin supplements with 126 capsules for each subject per phase. Randomization was done with sealed envelopes.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Vitamin B complex (natural vs. synthetic) administered in capsules each day for 6 weeks - 2 weeks wash-out phase I (2 weeks) - cross-over 6 weeks - wash-out phase II (6 weeks)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 8, 2018

First Posted

February 23, 2018

Study Start

May 8, 2017

Primary Completion

October 3, 2017

Study Completion

November 17, 2017

Last Updated

April 26, 2021

Results First Posted

April 26, 2021

Record last verified: 2021-04

Locations